Vertex Pharma profit tops estimates on strong launch of new CF drug
(Reuters) - Vertex Pharmaceuticals Inc topped analysts' forecasts for quarterly profit on Thursday, led by stronger-than expected sales of its latest cystic fibrosis drug as well as double-digit growth in sales of older treatments.
from Reuters: Health News https://reut.rs/2JwleRg
http://bit.ly/2zwRqiM
April 26, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on April 26, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.